Chinese PLA General Hospital: Kidney Diseases trials
The registry lists 14 Kidney Diseases studies with Chinese PLA General Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 4 5No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic NephropathyRecruitingNCT06843304
- Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic RetinopathyNot yet recruitingNCT06660940Phase 4
- Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney DiseaseRecruitingNCT05938140Phase 4
- Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes NephropathyRecruitingNCT05888909
- Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyRecruitingNCT05839314Phase 4
- Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic NephropathyRecruitingNCT03865914
- 24-hour Urinary Electrolyte Excretion in Chronic Kidney DiseaseCompletedNCT05550467
- Effect of Hydration Guided by Vigileo on the Prevention of CIN After PCI for Patients With AMICompletedNCT04382313Not applicable
- Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)Status unknownNCT03246204
- Screening and Assessing the Risk Factors and Complications of Chronic Kidney DiseaseStatus unknownNCT03246191
- Effect Insulin Pump Therapy to Patients With Diabetic NephropathyCompletedNCT03174821Not applicable
- Efficacy Study of Vitamin D to Treat Contrast-induced NephropathyStatus unknownNCT02489240Not applicable
- Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney DiseaseStatus unknownNCT02299310Phase 4
- Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney DiseaseStatus unknownNCT02231138Phase 4